CurrentEndo
Get Weekly

Topic · page 9 of 12

Lipids & metabolic liver disease

Lipid disorders and metabolic dysfunction-associated steatotic (fatty) liver disease, as published in the endocrine journals

Briefs 321–360 of 460 placed here, newest publication first

Briefs in Lipids & metabolic liver disease

Newest publication first

  1. Cardiovasc Diabetol

    Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome

    Cohort study

  2. Cardiovasc Diabetol

    Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease

    Cohort study

  3. Diabetologia

    Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study

    Cohort study

  4. Obesity (Silver Spring)

    The grade of obesity affects the noninvasive diagnosis of advanced fibrosis in individuals with MASLD

    Diagnostic or prognostic study

  5. Cardiovasc Diabetol

    The association between triglyceride-glucose index and the likelihood of cardiovascular disease in the U.S. population of older adults aged ≥ 60 years: a population-based study

    Cross-sectional study

  6. Endocr Pract

    Racial Disparities in Evidence-Based Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes

    Cross-sectional study

  7. Endocr Pract

    Role of Resmetirom, a Liver-Directed, Thyroid Hormone Receptor Beta-Selective Agonist, in Managing Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis

    Meta-analysis

  8. Diabetes Obes Metab

    Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: A 3‐year prospective cohort study

    Cohort study

  9. Cardiovasc Diabetol

    Prediction of various insulin resistance indices for the risk of hypertension among military young adults: the CHIEF cohort study, 2014–2020

    Cohort study

  10. Cardiovasc Diabetol

    Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome

    Cohort study

  11. Cardiovasc Diabetol

    Longitudinal blood glucose level and increased silent myocardial infarction: a pooled analysis of four cohort studies

    Meta-analysis

  12. Diabetes Obes Metab

    A meta‐analysis of the association between RBP4 rs3758539 genotype and metabolic syndrome factors

    Meta-analysis

  13. J Clin Endocrinol Metab

    Effects of Hypertriglyceridemia With or Without NEFA Elevation on β-cell Function and Insulin Clearance and Sensitivity

    Mechanistic study

  14. J Clin Endocrinol Metab

    LDL-C and TC Mediate the Risk of PNPLA3 Inhibition in Cardiovascular Diseases

    Research article

  15. J Clin Endocrinol Metab

    Prevalence of Dysbetalipoproteinemia in the UK Biobank According to Different Diagnostic Criteria

    Cross-sectional study

  16. Diabetes Metab

    Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography

    Cohort study

  17. J Clin Endocrinol Metab

    Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome

    Cohort study

  18. Diabet Med

    Association of physical activity and sports participation with insulin resistance and non‐alcoholic fatty liver disease in people with type 1 diabetes

    Cross-sectional study

  19. Cardiovasc Diabetol

    Association between triglyceride–glucose index trajectories and radiofrequency ablation outcomes in patients with stage 3D atrial fibrillation

    Cohort study

  20. Diabetes Res Clin Pract

    Diagnostic performance of the GGT/HDL-C ratio for NAFLD in adults with obesity undergoing bariatric surgery

    Cross-sectional study

  21. JAMA Intern Med

    Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease

    Cohort study

  22. JAMA Netw Open

    Racial Discrimination and Metabolic Syndrome in Young Black Adults

    Cohort study

  23. Diabetes Res Clin Pract

    The hidden epidemic: Uncovering incidental fatty liver disease and its metabolic comorbidities by datamining in a hospital data lake – A real-world cohort study

    Cohort study

  24. Cardiovasc Diabetol

    Sex differences in the relationship between serum total bilirubin and risk of incident metabolic syndrome in community-dwelling adults: Propensity score analysis using longitudinal cohort data over 16 years

    Cohort study

  25. Pediatr Obes

    Food insecurity is a risk factor for metabolic dysfunction‐associated steatotic liver disease in Latinx children

    Cohort study

  26. J Clin Endocrinol Metab

    Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China

    Cohort study

  27. Obesity (Silver Spring)

    Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLD

    Mechanistic study

  28. J Clin Endocrinol Metab

    High hsCRP Concentration Is Associated With Acute Pancreatitis in Multifactorial Chylomicronemia Syndrome

    Cohort study

  29. J Clin Endocrinol Metab

    Magnesium Depletion Score and Metabolic Syndrome in US Adults: Analysis of NHANES 2003 to 2018

    Cross-sectional study

  30. Cardiovasc Diabetol

    Association of the triglyceride glucose index with all-cause and cardiovascular mortality in a general population of Iranian adults

    Cohort study

  31. J Clin Endocrinol Metab

    Machine Learning Identifies Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Diabetes Mellitus

    Diagnostic or prognostic study

  32. Cardiovasc Diabetol

    Revisiting an old relationship: the causal associations of the ApoB/ApoA1 ratio with cardiometabolic diseases and relative risk factors—a mendelian randomization analysis

    Research article

  33. Diabetes Obes Metab

    Baseline and change in serum uric acid level over time and resolution of nonalcoholic fatty liver disease in young adults: The Kangbuk Samsung Health Study

    Cohort study

  34. Lancet Diabetes Endocrinol

    PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial

    Randomized controlled trial

  35. J Clin Endocrinol Metab

    The Lipoprotein Profile Evaluated by 1H-NMR Improves the Performance of Genetic Testing in Familial Hypercholesterolemia

    Diagnostic or prognostic study

  36. Obesity (Silver Spring)

    Effects of time‐restricted eating on intrahepatic fat and metabolic health among patients with nonalcoholic fatty liver disease

    Randomized controlled trial

  37. Cardiovasc Diabetol

    Remnant cholesterol and the risk of aortic valve calcium progression: insights from the MESA study

    Cohort study

  38. Endocr Pract

    Safety-Net Primary Care and Endocrinology Clinicians’ Knowledge and Perspectives on Screening for Nonalcoholic Fatty Liver Disease: A Mixed-Methods Evaluation

    Cross-sectional study

  39. Cardiovasc Diabetol

    Relationship between triglyceride-glucose index baselines and trajectories with incident cardiovascular diseases in the elderly population

    Cohort study

  40. Cardiovasc Diabetol

    Central and peripheral blood pressures in relation to the triglyceride-glucose index in a Chinese population

    Cross-sectional study

All 460 Briefs in ExploreShowing Briefs 321–360 of 460, newest first